In November 2024, CMS proposed a rule change that would have allowed Medicare Part D to cover drugs prescribed for weight loss to treat obesity, starting in 2026
Its Not Just About SterilityIts Also About Stability
Many clients experience significant weight reduction, with an average weight loss of 15-20% of their body weight over the course of treatment
Pharmacology & Therapeutics, 117(1), 105122
Patients should consider the financial commitment alongside potential health benefits when deciding whether to pursue private GLP-1 treatment, and check current NHS prescription charges via the NHS Business Services Authority website
For women 40+, expect 0.51 pound per week with more weekly fluctuation due to hormonal cycles, water retention, and cortisol sensitivity